Skip to content

Clorox stock

CLXNYSE

The Clorox Company, Consumer DefensiveISIN US1890541097

$106.86▲ $0.26 (+0.2%)Closing price of 11 Nov 2026

62Score 62 out of 100, Neutral

Turn on early warning

Price and trend

60 / 100

Price history

+1.7% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 7.6% above it.

Trend change

Since March 2025 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Overheated: the price has risen very quickly lately (RSI 86).

Distance to the high

The price is 16% below its 52-week high. Largest decline in 20 years: 66% (August 2020 to October 2026).

Chart figures for advanced users
SMA 50$88.19
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$99.31
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)86
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$80.41
The lowest closing price of the last twelve months.
Resistance$127.16
The highest closing price of the last twelve months.
Market cap
$12.92B
Div. yield
4.66%
12 months
19.3
18.2
on earnings for the next twelve months ($5.89 per share)
Fair value
$115.05

Snapshot

Computed from the data by fixed rules, no AI

  • The Clorox Company belongs to the Household & Personal Products industry (United States) and, with a market value of $12.92B, is number 14 of 39 companies in its industry on MEQIRI.
  • In fiscal 2026 it reported revenue of $6.72B (down 5.4% year on year) and earnings of $587M (down 27.5%).
  • For fiscal 2027, analysts expect on average revenue of $7.64B (up 13.7%) and adjusted earnings per share of $5.73 (up 3.4%).
Show more
  • MEQIRI Score 62 out of 100 (Neutral): rank 155 of 295 in Consumer Defensive, median 62.
  • The P/E is 19.3 (Household & Personal Products median 23.9, own median of recent years 27).
  • Our model puts fair value at $115.05, with the price 7% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Reliable dividendNo dividend cut for 43 years.Capital allocation 82
  • High return on capitalReturn on invested capital 28.6% in fiscal 2026, Household & Personal Products median 9%.Profitability 76
  • High dividend yieldDividend yield 4.66%, Household & Personal Products median 2.47%.Capital allocation 82

Weaknesses

None of our weakness checks flags anything. Crash risk is measured separately.

62/ 100
MEQIRI Score
Neutral

Its standout strengths are fundamentals and capital allocation, while stability and growth hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Fundamentals are strong, with stable profits.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)67%
ROIC (12 months)33.9%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk low

How well MEQIRI warns

One of the 30% with the lowest crash risk among smaller stocks.

From 2016 to 2025, 14 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What lowers it

  • solid fundamentals
  • low growth grade (crashed less often in the backtest)

Valuation

Valuation signal

Fairly valued
Price
$106.86
Fair value
$115.05
Gap to fair value
−7%

In our model the price counts as cheap below $88.50 and expensive above $164.36 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $97.79 (cash-flow model) and $132.32 (industry comparison), and the gap between them shows how uncertain the estimate is.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $106.73, at 7.8% it would be $127.56.

Valuation metrics

3.67
14
Fair value (model)
$115.05
Earnings part $132.32 (earnings per share $5.55 × 23.9)

Half from the cash-flow model, half from earnings times the industry P/E (23.9).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue rose 6.3% on the twelve months before. Revenue has stayed largely stable since 2007.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2026: gross 42%, operating 25%, net 9%.

Debt & balance sheet

latest quarter
46.23
7.1x
0.65
Cash & equivalents
$184M

Debt is elevated. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
2 Feb 2027in 82 days
Last reported
2 Nov 2026EPS reported $1.55 (expected $1.07)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 202712 analysts
Earnings per share
$5.73−0.2%
Revenue
$7.64B+0.1%
Fiscal 202812 analysts
Earnings per share
$6.16−0.6%
Revenue
$7.81B0.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: +9.6%

Fiscal 2027 outlook assumes continued muted categories, a slower first quarter and inflation above $200 million; the company gave no comparison with earlier figures.

Supporting passage from the call, verbatim
“So we expect fiscal year '27 inflation to be above $200 million.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 3 Aug 2026 (fiscal Q4 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

One insider bought on the open market in the last 6 months, $400,251 in total.

  • Breber Pierre RPurchase

    4 Nov 2026, Board

    Shares
    4,000
    Price
    $100.06
    Value
    $400,251

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Clorox

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

295 rated companies in Consumer Defensive

Rank 155 of 295
155/ 295
This company
62
Sector median
62

Categories against the sector median

ProfitabilityMedian of 295 companies76 (median 54)22 above the median
GrowthMedian of 295 companies22 (median 50)28 below the median
FundamentalsMedian of 295 companies88 (median 79)9 above the median
ValuationMedian of 290 companies with a value56 (median 65)9 below the median
StabilityMedian of 295 companies39 (median 68)29 below the median
Capital allocationMedian of 295 companies82 (median 62)20 above the median
Technical analysisMedian of 295 companies60 (median 65)5 below the median
MomentumMedian of 295 companies72 (median 60)12 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Household & Personal Products

The next larger and next smaller companies by market value

All 39 Household & Personal Products stocks

ETFs that hold Clorox

Held by 40 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 11 Nov 2026
Latest annual report
Fiscal year 2026, period end 30 Jun 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 30 Apr 2021)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy